The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
764
April 22, 1988
View Complete Issue         Table of Contents 2019 
Issue 764
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Fluoxetine For Depression
April 22, 1988 (Issue: 764)
Fluoxetine (Prozac - Dista), a phenylpropylamide, is the first serotonin-reuptake blocker introduced in the USA for treatment of . It is being promoted as causing fewer adverse effects than other antidepressants. Claims of greater safety and ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 764
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.